5th ESO-SIOP Europe Masterclass in Paediatric Oncology
30 ESCO credits
17.05.2014 - 22.05.2014
Ljubljana
MASTERCLASS
Description
Chairs: R. Riccardi, IT - M.C.G. Stevens, UK - A. Eggert, DE
Co-Chair: B. Morland, UK
Educational Advisor: W. Gatzemeier, IT
ESO and SIOP-Europe are pleased to announce the fifth Masterclass in Paediatric Oncology. This clinically-oriented educational programme has been designed for young paediatric oncologists who wish to improve their skills in clinical management of common childhood tumours. It is designed to offer a unique learning experience, providing practice-oriented training and the teaching sessions will focus on the application of the most recent research findings to clinical practice.
LEARNING OBJECTIVES
• Qualified training in paediatric oncology to improve their knowledge of the main topics listed below.
• Skills in dealing with cancer problems as a whole
• Knowledge of current clinical practice and state of the art treatment
MAIN TOPICS
• Central nervous system tumours
• Neuroblastoma
• Soft-tissue sarcoma
• Bone tumours
• Wilms’ tumour
• Rare tumours
The Masterclass in Paediatric Oncology is an ESO-SIOP Europe joint event | |||||||
![]() | |||||||
ESO is particularly grateful to the following organisation for his support: | |||||||
![]() | |||||||
![]() | |||||||
General information
ORGANISING SECRETARIAT
Alexandra Zampetti
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
6500 Bellinzona - Switzerland
Tel: +41 91 820 0954
Fax: +41 91 820 0953
Email: azampetti@eso.net
CME ACCREDITATION AND CERTIFICATE
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
TRAVEL GRANTS - ASSOCIAZIONE CORRERE PER LA SPERANZA
ESO and SIOP-E are grateful to the Italian association: Associazione Correre per la Speranza (www.lacorsadellasperanza.org) for having provided:
• Travel grants to support the participation of Italian paediatric oncologists in the Masterclass.
- The request for a travel grant must be mentioned in the letter accompanying the application, indicating the amount needed to cover travel costs.
- Registration, travel and accommodation costs will be covered by the grant.
The outcome for the grant application will be made known mid-April.
Faculty list
FACULTY
S. Ayme, Orphanet, INSERM US14, Paris, FR
S. Bielack, Olgahospital, Dept. of Oncology, Stuttgart, DE
H.N. Caron, Academic Medical Centre, Emma’s Children Hospital, Amsterdam, NL
F. Doz, Institut Curie, Paediatric Department, Paris, FR
J.C. Dupont, Institut Curie, Paediatric Department, Paris, FR
A. Eggert, Charité - Berlin University, Department of Paediatric Oncology/ Haematology, Berlin, DE
D. Ford, University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth Hospital, Birmingham, UK
J. Grill, Institut Gustave Roussy, Department of Pediatrics, Villejuif, FR
D. Hargrave, Royal Marsden Hospital, Department of Paediatric Oncology, Surrey, UK
L. Hjorth, Skåne University Hospital, Department of Paediatrics, Lund, SE
D. Körholz, Universitätsklinikum, Halle, Halle, DE
B. Morland, Birmingham Childrens’ Hospital, Birmingham, UK
D. Orbach, Institut Curie, Paediatric Department, Paris, FR
A. Peet, Birmingham Children’s Hospital, Birmingham, UK
R. Riccardi, Policlinico Universitario A. Gemelli, Div. of Paediatric Oncology, Roma, IT
D. Schneider, Klinikum Dortmund, Children’s Department, Dortmund, DE
F. Spreafico, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
E. Steliarova-Foucher, International Agency for Research in Cancer, Lyon, FR
M.C.G. Stevens, Royal Hospital for Children, Dept. of Oncology, Bristol, UK
G.Vassal, Institut Gustave Roussy, Department of Pediatric and Clinical Pharmacology, Villejuif, FR
.
Programme
17 May
| Arrival |
16:00 | Registration |
20:00 | Welcome from the chairs followed by dinner |
18 May
08:00 | Multiple choice pre-test |
BONE TUMOURS | |
08:30 | Osteosarcoma and Ewing sarcoma: Presentation, diagnostic and therapeutic approaches |
10:30 | Coffee break |
11:00 | Case presentations |
11:30 | Key note lecture Pediatric Cancer Epidemiology and cases |
12:30 | Lunch |
14:00 | Case presentations |
RARE TUMOURS | |
14:30 | Introduction to rare tumours |
15:00 | Germ Cell Tumours D. Schneider, DE |
15:45 | Hepatoblastoma B. Morland, UK |
16:30 | Coffee break |
17:00 | Case presentations |
20:00 | Dinner |
19 May
NEUROBLASTOMA | |
08:00 | State-of-the-Art in neuroblastoma therapy H. Caron, NL |
09:00 | On the way to personalized medicine approaches in neuroblastoma diagnostics and treatment |
10:00 | Coffee break |
10:30 | Case presentations |
11:30 | Key note lecture Personalised medicines in cancer: myth or a reality? G. Vassal, FR |
12:30 | Lunch |
13:15 | Case presentations |
| Free afternoon in Ljubjana followed by dinner |
20 May
SOFT TISSUE SARCOMA | |
08:00 | Rhabdomyosarcoma M.C.G. Stevens, UK |
09:00 | Non Rhabdo Soft Tissue Sarcoma |
10:00 | Questions and discussion M.C.G. Stevens, UK - D. Orbach, FR |
10:15 | Coffee break |
10:45 | Key note lecture Early phase studies |
11:45 | Case presentations |
13:00 | Lunch |
14:00 | Case presentations |
15:00 | Key note lecture Ethics - case based discussion F. Doz, FR - J-C. Dupont, FR |
16:00 | Coffee break |
16:30 | Overview: Hodgkin's Lymphoma D. Körholz, DE |
17:30 | Key note lecture Radiobiology and radiotherapy techniques D. Ford, UK |
20:00 | Dinner |
21 May
CNS TUMOURS | |
08:00 | Introduction |
08:45 | High grade gliomas of the brain and brainstem: towards biology - driven treatment |
09:15 | Low grade gliomas |
09:45 | Medulloblastoma |
10:15 | Coffee break |
10:45 | Ependymomas |
11:15 | Case presentations |
12:30 | Lunch |
13:30 | Key note lecture Survivorship |
14:30 | Case presentations |
15:30 | Coffee break |
16:00 | Case presentations |
16:45 | Key note lecture Problems and solutions in the |
22 May
08:00 | Wilms Tumour |
09:30 | Case presentations |
10:00 | Coffee break |
10:30 | Multiple choice test |
11:00 | Discussion and closure |